Study of Posaconazole in the Treatment of Invasive Fungal Infections (Study P02095)

NCT00034632 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Mycoses

Interventions

DRUG: Posaconazole oral suspension

Sponsor

Merck Sharp & Dohme LLC